| Fri, Jul 10, 2009 | | • | Blood Thinner's Approval A Muted Win For Lilly
at Forbes.com (Fri 6:40pm)
| | • | Approval of Effient, a Plavix Rival, Boosts Japanese Drug Maker
at The Wall Street Journal Online (Fri 5:12pm)
| | • | Is the News Good or Bad? Who Cares! Sell!
at Motley Fool (Fri 4:11pm)
| | Thu, Jul 9, 2009 | | • | Swine Flu Update: Vaccine for Kids, Tamiflu Resistance
at The Wall Street Journal Online (Thu, Jul 9)
| | • | Homeland Security Braces for Possible H1N1 Outbreak
at CNBC (Thu, Jul 9)
| | Wed, Jul 8, 2009 | | • | Is Bayer Eyeing Possible Animal Health Assets?
at The Wall Street Journal Online (Wed, Jul 8)
| | • | EU warns of antitrust probes into drug makers
AP (Wed, Jul 8)
| | • | Sector Snap: Pharma stocks flat in wake of probe
AP (Wed, Jul 8)
| | • | Amgen's Denosumab Strengthens Bones, Stocks
Indie Research (Wed, Jul 8)
| | Tue, Jul 7, 2009 | | • | Glaxo Missed the Boat
at Motley Fool (Tue, Jul 7)
| | • | Big Pharma Looks To Branded Generics In Developing World
at The Wall Street Journal Online (Tue, Jul 7)
| | Mon, Jul 6, 2009 | | • | Sanofi-Aventis study shows Lantus safety on eyes
AP (Mon, Jul 6)
| | • | 5-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH
PR Newswire (Mon, Jul 6)
| | Fri, Jul 3, 2009 | | • | European media stocks make gains
at FT.com (Fri, Jul 3)
| | Thu, Jul 2, 2009 | | • | Sanofi-Aventis arrhythmia drug Multaq approved
AP (Thu, Jul 2)
| | • | Likely FDA Approval Gives Dendreon A Lift
Investor's Business Daily (Thu, Jul 2)
| | • | At Last, a Heartening Drug Approval
at Motley Fool (Thu, Jul 2)
| | • | Multaq Approval Marks Comeback for Sanofi's Heart Drug
at The Wall Street Journal Online (Thu, Jul 2)
| | • | FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
PR Newswire (Thu, Jul 2)
| | • | FDA approves Sanofi cardiac drug
at MarketWatch (Thu, Jul 2)
|
Add SNY News to My Yahoo!:
 
| |
|
0.45% Nasdaq 
0.20%
Headlines
